Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Change in Receivables: 2009-2024

Historic Change in Receivables for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $95.8 million.

  • Select Medical Holdings' Change in Receivables fell 27204.22% to -$83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.6 million, marking a year-over-year decrease of 6937.54%. This contributed to the annual value of $95.8 million for FY2024, which is 839109.0% up from last year.
  • According to the latest figures from FY2024, Select Medical Holdings' Change in Receivables is $95.8 million, which was up 839109.0% from -$1.2 million recorded in FY2023.
  • Select Medical Holdings' Change in Receivables' 5-year high stood at $116.6 million during FY2020, with a 5-year trough of -$23.1 million in FY2021.
  • Its 5-year average for Change in Receivables is $48.1 million, with a median of $52.2 million in 2022.
  • Per our database at Business Quant, Select Medical Holdings' Change in Receivables tumbled by 11981.2% in 2021 and then soared by 839109.0% in 2024.
  • Select Medical Holdings' Change in Receivables (Annual) stood at $116.6 million in 2020, then crashed by 119.81% to -$23.1 million in 2021, then surged by 325.89% to $52.2 million in 2022, then crashed by 102.22% to -$1.2 million in 2023, then skyrocketed by 8391.09% to $95.8 million in 2024.
  • Its Change in Receivables was $95.8 million in FY2024, compared to -$1.2 million in FY2023 and $52.2 million in FY2022.